NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • NIHR Imperial BRC Primary Care Research Unit (PCRU)
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Prevention Stories

DiagnosticEventInnovationPrevention Inflammation biomarkers identify risk of severe COVID-19 for cancer patients

DiagnosticEventInnovationPrevention Inflammation biomarkers identify risk of severe COVID-19 for cancer patients

Published on 14th December 2020
Informatics ApproachesPrevention Coronavirus prevalence has fallen nationally with R below 1, REACT study shows

Informatics ApproachesPrevention Coronavirus prevalence has fallen nationally with R below 1, REACT study shows

Published on 1st December 2020

First in HumanGuidelinePreventionVideo Be Part Of COVID-19 Vaccine Research – UK

Published on 13th November 2020
Informatics ApproachesInnovationPartnershipPrevention Link between depression and bowel conditions

Informatics ApproachesInnovationPartnershipPrevention Link between depression and bowel conditions

Published on 12th November 2020
DiagnosticInnovationPrevention Wrinkled ‘super pea’ could be added to foods to reduce diabetes risk

DiagnosticInnovationPrevention Wrinkled ‘super pea’ could be added to foods to reduce diabetes risk

Published on 30th October 2020
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Treatment New Study Explores Vaccine Effectiveness for Inflammatory Bowel Disease
  • Prevention Detection of Asymptomatic Malaria Cases Using Rapid Diagnostic Tools
  • DiagnosticPrevention St Mary’s Pilots Rapid Blood Test to Detect Life-Threatening Conditions in Children
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre